EktoTherix
Clinical- Indications
- Acute wounds, Surgical wounds
Company intelligence / Profile preview
Neotherix
York, England, United Kingdomneotherix.com ↗
- Ownership
- Private
- Employees
- ~3
- Development stage
- Clinical
01
Overview
Neotherix has developed several advanced wound healing devices using electrospun bioresorbable scaffolds. Early clinical experience with their lead product, EktoTherix™, suggests accelerated granulation and epithelialization in acute and surgical wound settings. Other products are in development for chronic/infected wounds, fistulas, and periodontal applications. No large-scale pivotal trial results or regulatory approvals reported as of June 2025.
- Therapeutic areas
- OtherDermatologyGastroenterologyInfectious Diseases
- Modalities
- DeviceHydrogel-based drug delivery therapy (for scaffolds)Polymer-based scaffold (bioresorbable scaffold)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Neotherix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neotherix.